Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Gong

Showing results (401-410 of 417) with videos related to

Pageof 42
Sort By:
Hepatology International|January 26, 2021
S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinomaLu-Nan Qi, Liang Ma, Fei-Xiang Wu, et al.
Signal Transduction and Targeted Therapy|October 16, 2020
Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samplesLing Leng, Ruiyuan Cao, Jie Ma, et al.
Food and Waterborne Parasitology|March 2, 2026
<i>Clonorchis sinensis</i> promotes hepatocellular carcinoma progression via a potential PTTG1-β-catenin-c-MYC axisTai-Xin Yang, Jie Zhang, Min-Jun Li, et al.
Cancer Research|June 20, 2018
Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular CarcinomaLu-Nan Qi, Bang-De Xiang, Fei-Xiang Wu, et al.
Cancer Immunology, Immunotherapy : CII|September 24, 2021
Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practiceKang Chen, Wei Wei, Lei Liu, et al.
Thrombosis and Haemostasis|April 15, 2020
Heparanase Facilitates PMA-Induced Megakaryocytic Differentiation in K562 Cells via Interleukin 6/STAT3 PathwayLu Ming Wan, Shi Kun Zhang, Su Bo Li, et al.
Journal of Visualized Experiments : Jove|June 15, 2026
Generation and Single-Cell Transcriptomic Analysis of Hepatocellular Carcinoma Organoids following Drug TreatmentDan He, Zhong Liang, Cheng-Yang Zhang, et al.
Chinese Medical Journal|July 20, 2007
B to O erythrocyte conversion by the recombinant alpha-galactosidaseYang-pei Zhang, Feng Gong, Guo-qiang Bao, et al.
Nature Communications|December 9, 2021
Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinomaWei Cheng, Hao-Long Li, Shao-Yan Xi, et al.
Science Translational Medicine|February 4, 2021
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugateFan-En Kong, Guang-Meng Li, Yun-Qiang Tang, et al.
Pageof 42

Showing results (401-410 of 417) with videos related to

Sort By:
Pageof 42
Hepatology International|January 26, 2021
S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinomaLu-Nan Qi, Liang Ma, Fei-Xiang Wu, et al.
Signal Transduction and Targeted Therapy|October 16, 2020
Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samplesLing Leng, Ruiyuan Cao, Jie Ma, et al.
Food and Waterborne Parasitology|March 2, 2026
<i>Clonorchis sinensis</i> promotes hepatocellular carcinoma progression via a potential PTTG1-β-catenin-c-MYC axisTai-Xin Yang, Jie Zhang, Min-Jun Li, et al.
Cancer Research|June 20, 2018
Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular CarcinomaLu-Nan Qi, Bang-De Xiang, Fei-Xiang Wu, et al.
Cancer Immunology, Immunotherapy : CII|September 24, 2021
Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practiceKang Chen, Wei Wei, Lei Liu, et al.
Thrombosis and Haemostasis|April 15, 2020
Heparanase Facilitates PMA-Induced Megakaryocytic Differentiation in K562 Cells via Interleukin 6/STAT3 PathwayLu Ming Wan, Shi Kun Zhang, Su Bo Li, et al.
Journal of Visualized Experiments : Jove|June 15, 2026
Generation and Single-Cell Transcriptomic Analysis of Hepatocellular Carcinoma Organoids following Drug TreatmentDan He, Zhong Liang, Cheng-Yang Zhang, et al.
Chinese Medical Journal|July 20, 2007
B to O erythrocyte conversion by the recombinant alpha-galactosidaseYang-pei Zhang, Feng Gong, Guo-qiang Bao, et al.
Nature Communications|December 9, 2021
Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinomaWei Cheng, Hao-Long Li, Shao-Yan Xi, et al.
Science Translational Medicine|February 4, 2021
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugateFan-En Kong, Guang-Meng Li, Yun-Qiang Tang, et al.
Pageof 42